BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10394718)

  • 1. Feasibility of antibody production in plants for human therapeutic use.
    Russell DA
    Curr Top Microbiol Immunol; 1999; 240():119-38. PubMed ID: 10394718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Plant-made pharmaceuticals].
    Faye L; Lerouge P; Gomord V
    Ann Pharm Fr; 2003 Mar; 61(2):109-18. PubMed ID: 12668949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plant biopharming of monoclonal antibodies.
    Ko K; Koprowski H
    Virus Res; 2005 Jul; 111(1):93-100. PubMed ID: 15896408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of pharmaceutical-grade recombinant aprotinin and a monoclonal antibody product using plant-based transient expression systems.
    Pogue GP; Vojdani F; Palmer KE; Hiatt E; Hume S; Phelps J; Long L; Bohorova N; Kim D; Pauly M; Velasco J; Whaley K; Zeitlin L; Garger SJ; White E; Bai Y; Haydon H; Bratcher B
    Plant Biotechnol J; 2010 Jun; 8(5):638-54. PubMed ID: 20514694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of antibodies in transgenic plants.
    Larrick JW; Yu L; Chen J; Jaiswal S; Wycoff K
    Res Immunol; 1998; 149(6):603-8. PubMed ID: 9835425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of monoclonal antibodies in plants for cancer immunotherapy.
    Moussavou G; Ko K; Lee JH; Choo YK
    Biomed Res Int; 2015; 2015():306164. PubMed ID: 26550566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody Production in Plants and Green Algae.
    Yusibov V; Kushnir N; Streatfield SJ
    Annu Rev Plant Biol; 2016 Apr; 67():669-701. PubMed ID: 26905655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plantibodies: applications, advantages and bottlenecks.
    Stoger E; Sack M; Fischer R; Christou P
    Curr Opin Biotechnol; 2002 Apr; 13(2):161-6. PubMed ID: 11950570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plant-Produced Monoclonal Antibody as Immunotherapy for Cancer.
    Nessa MU; Rahman MA; Kabir Y
    Biomed Res Int; 2020; 2020():3038564. PubMed ID: 32908881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plant Factories for the Production of Monoclonal Antibodies.
    Sheshukova EV; Komarova TV; Dorokhov YL
    Biochemistry (Mosc); 2016 Oct; 81(10):1118-1135. PubMed ID: 27908237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and characterization of an anti-(hepatitis B surface antigen) glycosylated mouse antibody in transgenic tobacco (Nicotiana tabacum) plants and its use in the immunopurification of its target antigen.
    Ramírez N; Rodríguez M; Ayala M; Cremata J; Pérez M; Martínez A; Linares M; Hevia Y; Páez R; Valdés R; Gavilondo JV; Selman-Housein G
    Biotechnol Appl Biochem; 2003 Dec; 38(Pt 3):223-30. PubMed ID: 12797866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of antibodies in plants: status after twenty years.
    De Muynck B; Navarre C; Boutry M
    Plant Biotechnol J; 2010 Jun; 8(5):529-63. PubMed ID: 20132515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycosylation of Plant-Produced Immunoglobulins.
    Göritzer K; Strasser R
    Exp Suppl; 2021; 112():519-543. PubMed ID: 34687021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From gene to harvest: insights into upstream process development for the GMP production of a monoclonal antibody in transgenic tobacco plants.
    Sack M; Rademacher T; Spiegel H; Boes A; Hellwig S; Drossard J; Stoger E; Fischer R
    Plant Biotechnol J; 2015 Oct; 13(8):1094-105. PubMed ID: 26214282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plant pharming of a full-sized, tumour-targeting antibody using different expression strategies.
    Villani ME; Morgun B; Brunetti P; Marusic C; Lombardi R; Pisoni I; Bacci C; Desiderio A; Benvenuto E; Donini M
    Plant Biotechnol J; 2009 Jan; 7(1):59-72. PubMed ID: 18793269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manufacturing of recombinant therapeutic proteins in microbial systems.
    Graumann K; Premstaller A
    Biotechnol J; 2006 Feb; 1(2):164-86. PubMed ID: 16892246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of rhizosecretion as a production system for recombinant proteins from hydroponic cultivated tobacco.
    Drake PM; Barbi T; Sexton A; McGowan E; Stadlmann J; Navarre C; Paul MJ; Ma JK
    FASEB J; 2009 Oct; 23(10):3581-9. PubMed ID: 19470800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-based metabolic engineering in plants.
    Nölke G; Fischer R; Schillberg S
    J Biotechnol; 2006 Jun; 124(1):271-83. PubMed ID: 16698105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibody manufacturing in transgenic plants--myths and realities.
    Hood EE; Woodard SL; Horn ME
    Curr Opin Biotechnol; 2002 Dec; 13(6):630-5. PubMed ID: 12482526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies for enhancing monoclonal antibody accumulation in plant cell and organ cultures.
    Sharp JM; Doran PM
    Biotechnol Prog; 2001; 17(6):979-92. PubMed ID: 11735430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.